HealthDay on MSN19h
Four in 10 Patients Receiving Chemo Develop Chronic Painful Neuropathy
The pooled prevalence of chronic painful neuropathy is 41.22% among individuals with chemotherapy-induced peripheral neuropathy (CIPN).
Inhibiting a gene provides a new weapon to fight treatment-resistant melanoma
The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant ...
Kaleido Scope14h
Leavenworth and Markert published in Nature Communications
For more information, refer to the full study in Nature Communications.